Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -59.5% | +1533.1% | 2 / 3 | +12.2% | -12.08 pp | -12.32 pp | +23.6% | 0.48 | 5.80 | 1.937 | +12,2% | 135 | −59,5% | 5.80 | 28.93 | −79,9% |
| Pts | 0 | 12 | 8 | 4 | 0 | 0 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 18.850 (close price on 2026-10-19)EPS (TTM): 3.248
Financial charts
1.Revenue & growth
VND bn1.937Q2/26
1.Revenue & growth
VND bn1.937Q2/26
2.Profit & growth
VND bn135Q2/26
3.Profit mix (Penman)
VND bn1.039Q2/26
4.Margins & cost structure
%19.6%Q2/26
5.Returns & cash cycle
% · days18.6%Q2/26
6.Earnings quality & cash
VND bn667Q2/26
7.Asset structure
VND bn6.434Q2/26
8.Funding & debt health
VND bn · times6.434Q2/26
9.Revenue backlog
VND bn46,2Q2/26
10.Valuation
times · %5,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %506Q2/26
Adjusted EPS growth, latest quarter
-59.5%
Average adjusted EPS growth, 3 quarters
16,3× higher
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26